Genticel

Activities: Research & Development Pharmaceutical

Trending Articles

  1. Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222 Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
  2. Overcoming CMC challenges in cell and gene therapy: part II Certara’s Dr Hien Anh Bruno, Associate Director, Chemistry, Manufacturing and Controls (CMC), and Dr Deven Shah, CMC Lead, propose mitigation strategies to address the CMC...
  3. SNIPR Biome receives funding to progress CRISPR medicine SNIPR001 into clinical trials Phase 1b/2a trial will evaluate SNIPR001 for the prevention of E.coli infections in patients undergoing hematopoietic stem cell transplantation
  4. Kindeva Drug Delivery appoints Denis Johnson as Chief Operating Officer Denis will be responsible for optimising global operations for the company
  5. SeaBeLife awarded over €1.5 million in i-Nov innovation competition Funding for company’s SeaBeEYE project will be used to develop a new therapeutic approach for geographic atrophy, a form of age-related macular degeneration

Upcoming event

Cleanroom Conference UK

22–23 May 2024 | Exhibition | Birmingham, UK See all

Related Content

Research & Development

Remi Palmantier becomes Chief Scientific Officer at Genticel

Will accelerate the discovery, development and integration of specific immunotherapies
Manufacturing

Genticel licenses Vaxiclase platform to Serum Institute of India for use in whooping cough vaccines

Agreement entitles Genticel to up to US$57m in upfront and milestones payments
Research & Development

Dr Gerald Moeller becomes Vice-President of supervisory board at Genticel

He is a former CEO of the Boehringer Mannheim Group
Research & Development

BT Pharma becomes Genticel and secures Euro 13m in funding

Genticel will focus its efforts on the prevention of cervical cancer in HPV infected women.
Subscribe now